Live tape
Top 8, mentions 7d6,975GOOGL1,565 mentions▲ +0.03NKE1,412 mentions▲ +0.03META1,012 mentions▲ +0.05NVDA884 mentions▲ +0.09TSLA603 mentions▲ +0.05MSFT512 mentions▲ +0.04AMZN495 mentions▲ +0.06RBA492 mentions▲ +0.05

Equity · Healthcare

BHC

NYSE

Bausch Health Companies Inc.

$5.83 +0.52% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 30, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$8 $4 6 Jul 30 Sep

The line runs $4.80 on 6 July through $5.83 on 30 September, on a scale from $4 to $8. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of BHC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $4.80 on 6 July 2026 through $5.83 on 30 September 2026.

Market cap $2.2B
52-week range $4.44 – $8
Avg volume 150.9K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 30, 2026

BHC insider trades

SEC Form 4 · last 90 days · newest reported trade 19 Aug 2026
Open-market buys 0
Open-market sells 1
Net sold $259K
Non-trade filings 3
Date Insider Type Shares Value
19 Aug 2026 Lenar Aimee J. President, US Pharma Sell 36,827 $259K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
17 Jul 2026 Lenar Aimee J. President, US Pharma Tax withheld 5,260 $25K
15 Jul 2026 Lenar Aimee J. President, US Pharma Tax withheld 23,395 $114K
14 Jul 2026 LEE STEVEN HYOSIG SVP, Controller & CAO Tax withheld 3,125 $15K

BHC reported financials

SEC EDGAR XBRL

BHC reported revenue of $10.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $157.0M.

Figure Reported Period
Revenue $10.3B 31 Dec 2025 fiscal year
Net income $157.0M 31 Dec 2025 fiscal year
Diluted EPS $0.42 31 Dec 2025 fiscal year
Total assets $24.8B 30 Jun 2026 at period end
Total equity −$1.8B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BHC earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.68 —
31 Mar 2026 Q1 2026 $-3.82 —
31 Dec 2025 FY 2025 $0.42 —
30 Sep 2025 Q3 2025 $0.48 —
30 Jun 2025 Q2 2025 $0.40 —
31 Mar 2025 Q1 2025 $-0.16 —
31 Dec 2024 FY 2024 $-0.13 —
30 Sep 2024 Q3 2024 $-0.23 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BHC institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a BHC position for the quarter ended 30 Jun 2026 — a combined $68.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Added +332.6% shares 2,689,942 $13.3M
Point72 Asset Management Added +65.6% shares 2,235,821 $11.0M
Two Sigma Investments Added +35.3% shares 2,135,582 $10.5M
Man Group Added +175.1% shares 1,451,781 $7.2M
Renaissance Technologies Held (±25%) −15.9% shares 1,324,549 $6.5M
Citadel Advisors Held (±25%) +21.1% shares 1,105,055 $5.4M
Millennium Management Added +150.7% shares 1,095,104 $5.4M
Bridgewater Associates Added +29.2% shares 866,285 $4.3M
GAMCO Investors Held (±25%) −5.5% shares 707,256 $3.5M
Marshall Wace New position 186,296 $918K

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Source: SEC EDGAR 13F filings

BHC fails-to-deliver

SEC CNS data

On 14 Sep 2026, 3,770 shares of BHC failed to deliver (about $22K).

Settlement date Shares failed Notional % of shares out
14 Sep 2026 3,770 $22K 0.001%
10 Sep 2026 108 $665 <0.001%
09 Sep 2026 7,678 $49K 0.002%
04 Sep 2026 2,267 $15K 0.001%
01 Sep 2026 450,836 $2.9M 0.121%
31 Aug 2026 107,686 $681K 0.029%
27 Aug 2026 48 $312 <0.001%
24 Aug 2026 15,263 $98K 0.004%
20 Aug 2026 153,549 $1.1M 0.041%
19 Aug 2026 650 $5K <0.001%
18 Aug 2026 650 $4K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in BHC

STOCK Act disclosures

The most recent congressional trade disclosed in BHC is a sale by Susie Lee (house, NV), dated 27 Aug 2020.

Date Member Type Amount
27 Aug 2020 filed 07 Oct 2020 Susie Lee house · Democrat–NV Sale $1K–$15K
06 Jan 2020 filed 25 Feb 2020 Susie Lee house · Democrat–NV Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures